mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.05 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.05 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.05 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.05 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.05 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.05 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.05 |
mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.05 |